Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Dabigatran Study in the Early Phase of Stroke. New Neuroimaging Markers and Biomarkers Study (SEDMAN STUDY)

NCT02742480 is registered in ClinicalTrials.gov with Hospital Mutua de Terrassa as lead sponsor.

NCT NCT02742480
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02742480 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Dabigatran Study in the Early Phase of Stroke. New Neuroimaging Markers and Biomarkers Study (SEDMAN STUDY)
Lead sponsor
Hospital Mutua de Terrassa
Phase
Observational
Overall status
Unknown status
Start date
June 28, 2016
Completion date
December 31, 2019
Enrollment
500 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cardioembolic stroke